HK1201759A1 - 4-methylpyrazole formulations 4- - Google Patents
4-methylpyrazole formulations 4-Info
- Publication number
- HK1201759A1 HK1201759A1 HK15102474.4A HK15102474A HK1201759A1 HK 1201759 A1 HK1201759 A1 HK 1201759A1 HK 15102474 A HK15102474 A HK 15102474A HK 1201759 A1 HK1201759 A1 HK 1201759A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- methylpyrazole
- formulations
- methylpyrazole formulations
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4816—Wall or shell material
- A61K9/4825—Proteins, e.g. gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US26738909P | 2009-12-07 | 2009-12-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1201759A1 true HK1201759A1 (en) | 2015-09-11 |
Family
ID=44145870
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK15102474.4A HK1201759A1 (en) | 2009-12-07 | 2015-03-10 | 4-methylpyrazole formulations 4- |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US9173850B2 (es) |
| EP (3) | EP3300732A1 (es) |
| JP (1) | JP5678088B2 (es) |
| KR (1) | KR101464053B1 (es) |
| CN (1) | CN102630162B (es) |
| AU (1) | AU2010328375B2 (es) |
| DK (2) | DK2467136T3 (es) |
| ES (2) | ES2646201T3 (es) |
| HK (1) | HK1201759A1 (es) |
| PT (2) | PT2774612T (es) |
| SG (2) | SG10201710156RA (es) |
| TW (1) | TWI490209B (es) |
| WO (1) | WO2011071805A1 (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5800669B2 (ja) | 2011-10-18 | 2015-10-28 | 大阪化成株式会社 | 抗菌・抗カビ性付与剤、繊維類加工剤及び抗菌・抗カビ性繊維類の製造方法 |
| EP3323412A1 (en) * | 2016-11-17 | 2018-05-23 | Amalicon Holding AG | Formulation comprising 4-methylpyrazole |
| KR102150040B1 (ko) * | 2018-10-16 | 2020-08-31 | 한국과학기술원 | 4-메틸피라졸을 포함하는 간암 예방 또는 치료용 조성물 |
| CN109452286B (zh) * | 2018-11-12 | 2020-11-06 | 青岛大学 | 甲吡唑在杀灭松材线虫中的应用 |
| CN109381458B (zh) * | 2018-12-16 | 2020-09-01 | 李志武 | 甲吡唑及其盐在制备抗癫痫药物中的用途 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6197787B1 (en) * | 1997-03-03 | 2001-03-06 | Sanofi-Synthelabo | Pharmaceutical formulations containing poorly soluble drug substances |
| US6120806A (en) * | 1997-06-25 | 2000-09-19 | Whitmire; David R. | Oral formulations for controlled release of alcohol deterrents |
| FR2807645B1 (fr) * | 2000-04-12 | 2005-06-03 | Oreal | Utilisation d'inhibiteurs de l'alcool deshydrogenase dans le traitement cosmetique des matieres keratiniques |
| AR036358A1 (es) * | 2001-08-28 | 2004-09-01 | Schering Corp | Un inhalador de dosis medidas que contiene una formulacion de suspension en aerosol para inhalacion, un proceso para la produccion de la formulacion, el producto y el uso de una formulacion para la manufactura de un medicamento de asma |
| ITBO20020284A1 (it) | 2002-05-14 | 2003-11-14 | Ima Spa | Macchina opercolatrice |
| KR100598713B1 (ko) | 2002-07-05 | 2006-07-10 | 시오노기쿠오리카프스 가부시키가이샤 | 캡슐 충전 밀봉 장치 |
| US8591946B2 (en) * | 2003-08-29 | 2013-11-26 | Veloxis Pharmaceuticals A/S | Modified release compositions comprising tacrolimus |
| US20050069587A1 (en) * | 2003-09-02 | 2005-03-31 | Modi Nishit Bachulal | Novel drug compositions and dosage forms of topiramate |
| US20080021083A1 (en) * | 2004-03-03 | 2008-01-24 | Daley Thomas E | 4-Methylpyrazole Formulations for Inhibiting Ethanol Intolerance |
-
2010
- 2010-12-06 PT PT141501387T patent/PT2774612T/pt unknown
- 2010-12-06 ES ES14150138.7T patent/ES2646201T3/es active Active
- 2010-12-06 AU AU2010328375A patent/AU2010328375B2/en not_active Ceased
- 2010-12-06 PT PT108364720T patent/PT2467136E/pt unknown
- 2010-12-06 DK DK10836472.0T patent/DK2467136T3/da active
- 2010-12-06 TW TW099142530A patent/TWI490209B/zh not_active IP Right Cessation
- 2010-12-06 SG SG10201710156RA patent/SG10201710156RA/en unknown
- 2010-12-06 CN CN201080053767.0A patent/CN102630162B/zh not_active Expired - Fee Related
- 2010-12-06 US US13/497,166 patent/US9173850B2/en not_active Expired - Fee Related
- 2010-12-06 WO PCT/US2010/059065 patent/WO2011071805A1/en active Application Filing
- 2010-12-06 EP EP17187679.0A patent/EP3300732A1/en not_active Withdrawn
- 2010-12-06 DK DK14150138.7T patent/DK2774612T3/da active
- 2010-12-06 KR KR1020127008347A patent/KR101464053B1/ko not_active IP Right Cessation
- 2010-12-06 EP EP10836472.0A patent/EP2467136B1/en not_active Not-in-force
- 2010-12-06 ES ES10836472.0T patent/ES2487634T3/es active Active
- 2010-12-06 SG SG2012041976A patent/SG181566A1/en unknown
- 2010-12-06 JP JP2012542236A patent/JP5678088B2/ja not_active Expired - Fee Related
- 2010-12-06 EP EP14150138.7A patent/EP2774612B1/en not_active Not-in-force
-
2015
- 2015-03-10 HK HK15102474.4A patent/HK1201759A1/xx unknown
- 2015-10-30 US US14/928,529 patent/US20160151332A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| AU2010328375A1 (en) | 2012-04-05 |
| EP2774612A1 (en) | 2014-09-10 |
| EP2774612B1 (en) | 2017-08-30 |
| EP2467136A1 (en) | 2012-06-27 |
| AU2010328375B2 (en) | 2015-08-27 |
| CN102630162A (zh) | 2012-08-08 |
| EP2467136A4 (en) | 2013-01-16 |
| US20120244217A1 (en) | 2012-09-27 |
| KR20120115483A (ko) | 2012-10-18 |
| ES2646201T3 (es) | 2017-12-12 |
| PT2467136E (pt) | 2014-08-26 |
| SG181566A1 (en) | 2012-07-30 |
| KR101464053B1 (ko) | 2014-11-20 |
| DK2774612T3 (da) | 2017-11-20 |
| US20160151332A1 (en) | 2016-06-02 |
| JP5678088B2 (ja) | 2015-02-25 |
| EP3300732A1 (en) | 2018-04-04 |
| TWI490209B (zh) | 2015-07-01 |
| US9173850B2 (en) | 2015-11-03 |
| JP2013512930A (ja) | 2013-04-18 |
| EP2467136B1 (en) | 2014-05-07 |
| CN102630162B (zh) | 2014-07-09 |
| ES2487634T3 (es) | 2014-08-22 |
| WO2011071805A1 (en) | 2011-06-16 |
| SG10201710156RA (en) | 2018-01-30 |
| PT2774612T (pt) | 2017-11-17 |
| DK2467136T3 (da) | 2014-08-11 |
| TW201127816A (en) | 2011-08-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201106050B (en) | Dye-polymers formulations | |
| IL219961A0 (en) | Abuse-resistant formulations | |
| GB0815435D0 (en) | Formulations | |
| GB2459691B (en) | Formulations | |
| GB0823269D0 (en) | Formulations | |
| IL269369A (en) | The vehicles are improved | |
| GB0919210D0 (en) | Formulations | |
| GB0907003D0 (en) | Formulation | |
| GB0821789D0 (en) | Formulations | |
| EP2307021A4 (en) | FORMULATIONS | |
| HK1201759A1 (en) | 4-methylpyrazole formulations 4- | |
| EP2413905A4 (en) | COMPOSITION | |
| ZA201107435B (en) | Pyrazole copmpound | |
| IL217390A0 (en) | Formulations | |
| GB0921378D0 (en) | Formulations | |
| GB0916030D0 (en) | Formulations | |
| GB0911213D0 (en) | Formulation | |
| GB0822171D0 (en) | Temisartan formulations | |
| GB0917744D0 (en) | Formulations | |
| GB0914489D0 (en) | Improved formulations | |
| GB0916106D0 (en) | Formulations | |
| GB0823493D0 (en) | Formulations | |
| GB0823486D0 (en) | Formulations | |
| GB0817079D0 (en) | Formulations | |
| GB0816876D0 (en) | Formulations |